UTMB has a stellar track record in countermeasure development against emerging viruses through partnership with government and industry. In response to the recent emergence of Ebola virus and SARS-CoV-2, UTMB has played a pivotal role in developing the first FDA-approved therapy and vaccine. To expand the success to other disease areas, UTMB launched the Institute for Drug Discovery in September 2021.
The mission of the Institute for Drug Discovery is to improve human health by:
- Discovering and developing clinical drug candidates
- Advancing knowledge of drug discovery
- Training next-generation drug hunters